Of the 391 studied patients, 43 (11.0%) were found to develop TB while receiving ART, and the risk of developing TB was independently increased among male patients, those with WHO clinical stage 3 and 4 AIDS illnesses and CD4 <200 cells/μl, and those who did not use IPT. Here, CD4 is linked to tuberculosis.